ARTICLE | Clinical News
AngioGenex preclinical data
March 3, 2014 8:00 AM UTC
In a mouse model of breast cancer, twice-daily AGX-51 significantly blocked tumor growth at a dose <7 mg/kg when given in combination with a taxane and completely blocked tumor-associated angiogenesis...